financialpost on Nostr: Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 ...

Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA® (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study
https://financialpost.com/globe-newswire/medicenna-provides-clinical-update-and-announces-first-complete-responder-in-mdna11-and-keytruda-pembrolizumab-combination-dose-escalation-arm-of-the-ability-1-study